Ckim Pharma Llp

Ckim Pharma Llp - pharma in Namchi, Sikkim, India. FY 2026 financials and compliance.
LLPIN AAI-2659 Incorporated 13 January 2017 ROC Kolkata HQ Namchi, Sikkim, India
Active Limited Liability Partnership pharma
Data last updated
Revenue · Latest
-
▲ 31.64% YoY
EBITDA · Latest
*****
▲ 27.36% YoY
Net profit · Latest
*****
▲ 35.95% YoY
Contribution obligation
₹1 Cr
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Last financials
Mar 2025
Balance sheet date

About Ckim Pharma Llp

Data last updated: 13 February 2026

Ckim Pharma Llp is a limited liability partnership company based in Namchi, Sikkim, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 January 2017, the LLP has been in operation for over 9 years.

Registered with ROC Kolkata under LLPIN AAI-2659.

Capital: a total obligation of contribution of ₹1 Cr. It is led by designated partners including Shankar Agarwal and Hemant Amrish Parikh.

Accounts filed on 31 March 2025. Office: Namchi Bazar Namchi, Sikkim, India – 737126.

Company Details of Ckim Pharma Llp
LLPIN AAI-2659
Incorporation Date 13 January 2017
Total Obligation of Contribution ₹1 Cr
ROC Kolkata
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Shankar Agarwal Designated Partner Hemant Amrish Parikh Designated Partner Girish Bhatt Designated Partner
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Namchi Bazar Namchi, Sikkim, India – 737126
  • Industry
    Pharma, Drug Formulation & Development
Company report
Ckim Pharma Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ckim Pharma Llp report

Financials, compliance, directors, charges, ownership and filings for Ckim Pharma Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Ckim Pharma Llp

Ckim Pharma Llp is currently managed by 4 designated partners, with 1 former designated partner having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Shankar Agarwal Designated Partner 13 Jan 2017 9 Years 5 Months Current
Hemant Amrish Parikh
Also directs: Viva Surbhi Biotech Llp, Vivanza Biosciences Limited, Vivanta Industries Limited and 5 more
Designated Partner 14 Aug 2020 5 Years 10 Months Current
Girish Bhatt
Also directs: Vitale Beverages Private Limited, Viva Energy Fertilizers Private Limited, Vitaaglobal Bioscience Private Limited and 5 more
Designated Partner 14 Aug 2020 5 Years 10 Months Current
Mahabir Agarwal Prasad
Also directs: Ckim Holidays Llp, Ckim Builders Llp, Ckim Developers Llp and 5 more
Designated Partner 13 Jan 2017 9 Years 5 Months Current
View all designated partners

Financials of Ckim Pharma Llp FY 2025 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF
What Is the Ownership and Shareholding Structure of Ckim Pharma Llp?

View Ckim Pharma Llp's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.

Shareholding Pattern (FY 2026)
Shareholding pattern chart
  • Promoters: **.**%
  • Public: **.**%
  • Others: **.**%
Shareholding Pattern over the Year
FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Promoters**.****.****.****.****.**
Public**.****.****.****.****.**
Others**.****.****.****.****.**

Full shareholding pattern with quarterly trends.

Charges & Borrowings Ckim Pharma Llp

Ckim Pharma Llp does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Ckim Pharma Llp

View historical data on people associated with Ckim Pharma Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Ckim Pharma Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Ckim Pharma Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Ckim Pharma Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Ckim Pharma Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Ckim Pharma Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Ckim Pharma Llp

MSME Payment Delays by Ckim Pharma Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Ckim Pharma Llp

Subsidiaries & Group Companies of Ckim Pharma Llp

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ckim Pharma Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Ckim Pharma Llp

MCA Filings & Documents of Ckim Pharma Llp

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Ckim Pharma Llp

Activity
31 Mar 2025
Ckim Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Activity
31 Mar 2025
Ckim Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Directors
14 Aug 2020
Hemant Amrish Parikh was appointed as a Designated Partner on 14 Aug 2020 & has been associated with this company since 5 years 10 months.
Directors
14 Aug 2020
Girish Bhatt was appointed as a Designated Partner on 14 Aug 2020 & has been associated with this company since 5 years 10 months.
Directors
13 Jan 2017
Shankar Agarwal was appointed as a Designated Partner on 13 Jan 2017 & has been associated with this company since 9 years 5 months.
Directors
13 Jan 2017
Mahabir Agarwal Prasad was appointed as a Designated Partner on 13 Jan 2017 & has been associated with this company since 9 years 5 months.

Frequently Asked Questions about Ckim Pharma Llp

Ckim Pharma Llp is an active limited liability partnership in the pharma sector based in Namchi, Sikkim, India. It was incorporated on 13 January 2017 (9+ years old) and is registered under LLPIN AAI-2659.

The current designated partners of Ckim Pharma Llp are:

The primary industry of Ckim Pharma Llp is pharma. The LLP specifically operates in drug formulation and development. The LLP is currently active in this sector.

Ckim Pharma Llp can be reached at the registered office: Namchi Bazar Namchi, Sikkim, India – 737126.

The total obligation of contribution is ₹1 Cr.

The LLP has its registered office at Namchi Bazar Namchi, Sikkim, India – 737126.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available